Foslinanib ( TRX-818 | TRX818 )

产品货号. M11045 CAS No. 1256037-60-1

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Foslinanib
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Foslinanib (TRX-818) 是一种口服生物利用剂，具有潜在的抗肿瘤和抗血管生成拟态 (VM) 活性。
产品描述

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.Liver Cancer Phase 2 Clinical
体外实验

——
体内实验

——
同义词

TRX-818 | TRX818
通路

Others
靶点

Other Targets
受体

Other Targets
研究领域

Cancer
适应症

Liver Cancer

CAS Number

1256037-60-1
分子量

365.253
分子式

C16H13FNO6P
纯度

>98% (HPLC)
溶解度

——
SMILES

O=P(O)(OC1=C(OC)C=CC(NC(C2=CC=CC(F)=C2)=C3)=C1C3=O)O
化学全称

2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin5-yl dihydrogen phosphate